Neurotrophins Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032

The global neurotrophins market was estimated to be US$ 4.67 Billion in 2022 and is expected grow at a CAGR of 7.8% between 2023 to 2032.

Neurotrophins are a family of growth factors that promote the survival and development of neurons. They play a crucial role in the growth and maintenance of the nervous system and are involved in several physiological and pathological processes such as learning and memory, neurodegenerative disorders, and pain management.

Some of the well-known neurotrophins include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3). These molecules act on target neurons through specific receptors and modulate intracellular signaling pathways to regulate gene expression, protein synthesis, and synaptic plasticity.

The development of drugs that target neurotrophins and their receptors has emerged as a promising approach in the treatment of various neurological and psychiatric disorders.

Market Drivers

Growing demand for personalized medicine is boosting the market growth

The neurotrophins market is driven by several factors such as the increasing incidence of neurological disorders, the growing demand for personalized medicine, and the growing focus on the development of novel drugs. The growing geriatric population is also contributing to the growth of the market, as older people are more susceptible to neurological disorders.

Pharmaceutical companies are investing in R&D to develop novel drugs that can effectively target these disorders, and the development of neurotrophin-based treatments has emerged as a promising area of research.

Additionally, the demand for minimally invasive treatments is also driving the growth of the neurotrophins market. Neurotrophins can be delivered via minimally invasive methods such as intrathecal injections, which minimizes the risk of side effects and makes the treatment more convenient for patients.

The favorable regulatory scenario for biologics and the growing demand for cost-effective treatments are also contributing to the growth of the market. The expanding healthcare infrastructure in developing countries and the growing trend of outsourcing drug development activities are also expected to contribute to the growth of the neurotrophins market in the coming years.

Product segmentation of Global Neurotrophins Market

Nerve Growth Factor (NGF) is the largest product type in the neurotrophins market

Based on the product, the market is segmented into Nerve Growth Factor, Brain Derived Neurotrophic Factor, Neurotrophin-3, and Dehydroepiandrosterone Sulfate.

Among these, the largest segment is the Nerve Growth Factor (NGF) segment owing to the fact that NGF has been extensively studied for its neuroprotective and neuroregenerative properties, and has been shown to be effective in the treatment of various neurological disorders such as Alzheimer's disease, Parkinson's disease, and others.

NGF has a high degree of specificity for nerve cells and has been found to be effective in promoting the growth, survival, and differentiation of nerve cells, making it an attractive target for the treatment of neurological disorders.

The fastest-growing segment of the neurotrophins market based on product is the Brain-Derived Neurotrophic Factor (BDNF) segment. This is due to the growing interest in the development of BDNF-based treatments for neurological disorders.

BDNF has been shown to play a critical role in the survival, growth, and differentiation of nerve cells, and has been found to be effective in the treatment of various neurological disorders such as depression, anxiety, and others. The increasing focus on the development of novel BDNF-based treatments for neurological disorders is driving the growth of this segment.

Application segmentation of Global Neurotrophins Market

Parkinson's Disease is the fastest-growing application in the Neurotrophins market

Based on the application, the market is segmented into Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Parkinson’s Disease, and other applications.

Among these, the largest segment in the market is Alzheimer's Disease, owing to the increasing incidence of Alzheimer's disease and the growing demand for effective treatments for this disorder. Alzheimer's disease is a growing public health concern, and there is a growing need for effective treatments for this disorder. Neurotrophins have shown promise as a potential treatment for Alzheimer's disease, and there is a growing focus on developing neurotrophin-based treatments for this disorder.

The fastest-growing segment in the market is Parkinson's Disease, due to the increasing incidence of Parkinson's disease and the growing demand for effective treatments for this disorder. Parkinson's disease is a debilitating neurological disorder, and there is a growing need for effective treatments for this disorder.

Neurotrophins have shown promise as a potential treatment for Parkinson's disease, and there is a growing focus on developing neurotrophin-based treatments for this disorder. Additionally, the increasing focus on developing new and innovative treatments for Parkinson's disease is also driving the growth of this segment.

End-users’ segmentation of Global Neurotrophins Market

Hospital is the largest end-user due to the growing demand for effective treatments for neurological disorders

Based on end-users, the market is segmented into Hospitals, Diagnostic Centers, and other applications.

Among these, the largest segment is Hospitals, due to the increasing number of hospitals and the growing demand for effective treatments for neurological disorders. Hospitals are the largest end-users of neurotrophins, as they are the primary providers of healthcare services for patients with neurological disorders.

Neurotrophins are widely used in hospitals for the treatment of a range of neurological disorders, and the growing demand for effective treatments for these disorders is driving the growth of the Hospitals segment.

The fastest-growing segment in the market is Diagnostic Centers, due to the increasing demand for personalized medicine and the growing focus on developing new and innovative treatments for neurological disorders. Diagnostic Centers are a significant end-user of neurotrophins, as they are responsible for providing diagnostic services and tests for patients with neurological disorders.

The growing demand for personalized medicine and the increasing focus on developing new and innovative treatments for neurological disorders is driving the growth of the Diagnostic Centers segment.

Regional trends of the Global Neurotrophins Market

Asia-Pacific region will lead the global neurotrophins market

Geographically, the global neurotrophins market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

Among these, the largest segment in the market is North America, owing to the high incidence of neurological disorders in the region, the growing demand for personalized medicine, and the increasing focus on developing novel drugs for the treatment of these disorders.

In North America, there is a high demand for effective treatments for neurological disorders, and companies are investing in R&D to develop new and innovative treatments for these disorders. Additionally, the presence of major pharmaceutical companies in North America is also driving the growth of the neurotrophins market in this region.

The fastest-growing segment in the market is Asia-Pacific, due to the increasing incidence of neurological disorders in the region, the growing demand for personalized medicine, and the increasing focus on developing novel drugs for the treatment of these disorders.

In Asia-Pacific, there is a growing focus on developing new and innovative treatments for neurological disorders, and companies are investing in R&D to develop new treatments for these disorders. Additionally, the increasing awareness about the importance of treating neurological disorders is also driving the growth of the neurotrophins market in Asia-Pacific.

Key players and market strategies:

The key growth strategies adopted by companies operating in the global neurotrophins market include collaborations, partnerships, and mergers & acquisitions. Companies are collaborating with other companies, academic institutions, and research organizations to develop new and innovative neurotrophin-based treatments. These collaborations allow companies to pool their resources and expertise, and to develop new and effective treatments for neurological disorders.

In addition, companies are also partnering with other companies to expand their product portfolios and to increase their market presence. These partnerships allow companies to access new markets and to introduce their products to new customer segments.

Mergers & acquisitions are also becoming increasingly common in the market, as companies seek to expand their product portfolios and to increase their market presence. Companies are acquiring other companies to gain access to their product portfolios, customer bases, and technologies.

Some of the biggest companies operating in the global neurotrophins market are AbbVie (USA), Alcon (Switzerland), Allergan (Ireland), AstraZeneca (UK), BioMarin Pharmaceutical (USA), Bristol-Myers Squibb (USA), Eli Lilly and Company (USA), GlaxoSmithKline (UK), Johnson & Johnson (USA), Merck & Co. (USA), Novartis (Switzerland), Pfizer (USA), Roche (Switzerland), Sanofi (France), Teva Pharmaceutical Industries (Israel), and many more.

Global Neurotrophins Market Segmentation:

By Product Type

• Nerve Growth Factor
• Brain Derived Neurotrophic Factor
• Neurotrophin-3
• Dehydroepiandrosterone Sulfate

By Application

• Alzheimer’s Disease
• Amyotrophic Lateral Sclerosis
• Parkinson’s Disease
• Other applications

By End-users

• Hospitals
• Diagnostic Centers
• Others

By Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  
  • Japan
  • India
  • China
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East & Africa
  •  UAE
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa
• South America
  • Brazil
  • Rest of South America

1. Introduction
   • Research Objectives
   • Report Assumptions
   • Research Methodology
   • Abbreviations
2. Preface
   • Market Definition
   • Report Scope and Market Segmentation
   • Research Highlights
3. Market Synopsis: Global Neurotrophins Market
4. Global Neurotrophins Market Qualitative Analysis
   • Trends
     • Market trends
     • Technology Trends
   • PESTLE Analysis (For 3 prominent countries)
   • Market Influencers
     • Driving Forces
     • Hindering Forces
     • Opportunities
   • COVID-19 impact
   • Porter’s Five Forces Analysis
   • Value Chain Analysis
5. Global Neurotrophins Market Analysis and Forecast, by Product Type
   • Overview and definitions
   • Key segment analysis
   • Global Neurotrophins Market Estimates (US$ Mn), by Product Type, 2019 – 2032
     • Nerve Growth Factor
     • Brain Derived Neurotrophic Factor
     • Neurotrophin-3
     • Dehydroepiandrosterone Sulfate

6. Global Neurotrophins Market Analysis and Forecast, by Application
   • Overview and definitions
   • Key segment analysis
   • Global Neurotrophins Market Estimates (US$ Mn), by Application, 2019 – 2032
     • Alzheimer’s Disease
     • Amyotrophic Lateral Sclerosis
     • Parkinson’s Disease
     • Other applications

7. Global Neurotrophins Market Analysis and Forecast, by End Use
   • Overview and definitions
   • Key segment analysis
   • Global Neurotrophins Market Estimates (US$ Mn), by End Use, 2019 – 2032
     • Hospitals
     • Diagnostic Centers
     • Others

8. Global Neurotrophins Market Analysis and Forecast, by Region
   • Overview and definitions
   • Key segment analysis
   • Global Neurotrophins Market Estimates (US$ Mn), by Region, 2019 – 2032
     • North America
     • Europe
     • Asia Pacific
     • Middle East & Africa
     • South America

9. North America Neurotrophins Market Analysis and Forecast
   • Overview and definitions
   • Key segment analysis
   • North America Neurotrophins Market Estimates (US$ Mn), by Product Type, 2019 – 2032
     • Nerve Growth Factor
     • Brain Derived Neurotrophic Factor
     • Neurotrophin-3
     • Dehydroepiandrosterone Sulfate
   • North America Neurotrophins Market Estimates (US$ Mn), by Application, 2019 – 2032
     • Alzheimer’s Disease
     • Amyotrophic Lateral Sclerosis
     • Parkinson’s Disease
     • Other applications
   • North America Neurotrophins Market Estimates (US$ Mn), by End Use, 2019 – 2032
     • Hospitals
     • Diagnostic Centers
     • Others
   • North America Neurotrophins Market Estimates (US$ Mn), by Country, 2019 – 2032
     • United States
     • Canada
     • Rest of North America

10. Europe Neurotrophins Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • Europe Neurotrophins Market Estimates (US$ Mn), by Product Type, 2019 – 2032
      • Nerve Growth Factor
      • Brain Derived Neurotrophic Factor
      • Neurotrophin-3
      • Dehydroepiandrosterone Sulfate
    • Europe Neurotrophins Market Estimates (US$ Mn), by Application, 2019 – 2032
      • Alzheimer’s Disease
      • Amyotrophic Lateral Sclerosis
      • Parkinson’s Disease
      • Other applications
    • Europe Neurotrophins Market Estimates (US$ Mn), by End Use, 2019 – 2032
      • Hospitals
      • Diagnostic Centers
      • Others
    • Europe Neurotrophins Market Estimates (US$ Mn), by Country, 2019 – 2032
      • Germany
      • United Kingdom
      • Italy
      • France
      • Spain
      • Rest of Europe

11. Asia Pacific Neurotrophins Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • Asia Pacific Neurotrophins Market Estimates (US$ Mn), by Product Type, 2019 – 2032
      • Nerve Growth Factor
      • Brain Derived Neurotrophic Factor
      • Neurotrophin-3
      • Dehydroepiandrosterone Sulfate
    • Asia Pacific Neurotrophins Market Estimates (US$ Mn), by Application, 2019 – 2032
      • Alzheimer’s Disease
      • Amyotrophic Lateral Sclerosis
      • Parkinson’s Disease
      • Other applications
    • Asia Pacific Neurotrophins Market Estimates (US$ Mn), by End Use, 2019 – 2032
      • Hospitals
      • Diagnostic Centers
      • Others
    • Asia Pacific Neurotrophins Market Estimates (US$ Mn), by Country, 2019 – 2032
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • Rest of Asia Pacific

12. Middle East & Africa Neurotrophins Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • Middle East & Africa Neurotrophins Market Estimates (US$ Mn), by Product Type, 2019 – 2032
      • Nerve Growth Factor
      • Brain Derived Neurotrophic Factor
      • Neurotrophin-3
      • Dehydroepiandrosterone Sulfate
    • Middle East & Africa Neurotrophins Market Estimates (US$ Mn), by Application, 2019 – 2032
      • Alzheimer’s Disease
      • Amyotrophic Lateral Sclerosis
      • Parkinson’s Disease
      • Other applications
    • Middle East & Africa Neurotrophins Market Estimates (US$ Mn), by End Use, 2019 – 2032
      • Hospitals
      • Diagnostic Centers
      • Others
    • Middle East & Africa Neurotrophins Market Estimates (US$ Mn), by Country, 2019 – 2032
      • UAE
      • Saudi Arabia
      • South Africa
      • Rest of MEA

13. South America Neurotrophins Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • South America Neurotrophins Market Estimates (US$ Mn), by Product Type, 2019 – 2032
      • Nerve Growth Factor
      • Brain Derived Neurotrophic Factor
      • Neurotrophin-3
      • Dehydroepiandrosterone Sulfate
    • South America Neurotrophins Market Estimates (US$ Mn), by Application, 2019 – 2032
      • Alzheimer’s Disease
      • Amyotrophic Lateral Sclerosis
      • Parkinson’s Disease
      • Other applications
    • South America Neurotrophins Market Estimates (US$ Mn), by End Use, 2019 – 2032
      • Hospitals
      • Diagnostic Centers
      • Others
    • South America Neurotrophins Market Estimates (US$ Mn), by Country, 2019 – 2032
      • Brazil
      • Argentina
      • Rest of South America

14. Competition Analysis – Global Neurotrophins Market
    • Market Composition
    • Market Share Analysis (%), by Supplier (2022)
    • Company Profiles
      • AbbVie
        • Business overview
        • Geographic presence
        • Product portfolio
        • Financial facts
        • Relevant news and strategic view
      • Alcon
      • Allergan
      • AstraZeneca
      • BioMarin Pharmaceutical
      • Bristol-Myers Squibb
      • Eli Lilly and Company
      • GlaxoSmithKline
      • Johnson & Johnson
      • Merck & Co.
      • Novartis
      • Pfizer
      • Roche
      • Sanofi
      • Teva Pharmaceutical Industries

15. Conclusion & Recommendations